Universe Pharmaceuticals Inc (UPC)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
2.03
-0.12
(-5.58%)
After-Hours: 20:00
Universe Pharmaceuticals Net Income (TTM): -6.163M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -6.163M |
| March 31, 2023 | -11.18M |
| September 30, 2022 | -8.737M |
| March 31, 2022 | 5.904M |
| September 30, 2021 | 11.32M |
| Date | Value |
|---|---|
| March 31, 2021 | 9.632M |
| September 30, 2020 | 7.558M |
| March 31, 2020 | 8.549M |
| September 30, 2019 | 7.552M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-11.18M
Minimum
Mar 2023
11.32M
Maximum
Sep 2021
2.715M
Average
7.552M
Median
Sep 2019
Net Income (TTM) Benchmarks
| Sinovac Biotech Ltd | -99.92M |
| CASI Pharmaceuticals Inc | -26.94M |
| Zai Lab Ltd | -334.62M |
| I-MAB | -206.53M |
| Gracell Biotechnologies Inc (DELISTED) | -70.85M |